| Online-Ressource |
Verfasst von: | Klotz, Rosa [VerfasserIn]  |
| Larmann, Jan [VerfasserIn]  |
| Klose, Christina [VerfasserIn]  |
| Bruckner, Thomas [VerfasserIn]  |
| Benner, Laura [VerfasserIn]  |
| Dörr-Harim, Colette [VerfasserIn]  |
| Tenckhoff, Solveig [VerfasserIn]  |
| Lock, Johan F. [VerfasserIn]  |
| Brede, Elmar-Marc [VerfasserIn]  |
| Salvia, Roberto [VerfasserIn]  |
| Polati, Enrico [VerfasserIn]  |
| Köninger, Jörg [VerfasserIn]  |
| Schiff, Jan-Henrik [VerfasserIn]  |
| Wittel, Uwe A. [VerfasserIn]  |
| Hötzel, Alexander [VerfasserIn]  |
| Keck, Tobias [VerfasserIn]  |
| Nau, Carla [VerfasserIn]  |
| Amati, Anca-Laura [VerfasserIn]  |
| Koch, Christian [VerfasserIn]  |
| Eberl, Thomas [VerfasserIn]  |
| Zink, Michael [VerfasserIn]  |
| Tomazic, Ales [VerfasserIn]  |
| Novak-Jankovic, Vesna [VerfasserIn]  |
| Hofer, Stefan [VerfasserIn]  |
| Diener, Markus K. [VerfasserIn]  |
| Weigand, Markus A. [VerfasserIn]  |
| Büchler, Markus W. [VerfasserIn]  |
| Knebel, Phillip [VerfasserIn]  |
| Group, for the PAKMAN Trial [VerfasserIn]  |
Titel: | Gastrointestinal complications after pancreatoduodenectomy with epidural vs patient-controlled intravenous analgesia |
Titelzusatz: | a randomized clinical trial |
Verf.angabe: | Rosa Klotz, Jan Larmann, Christina Klose, Thomas Bruckner, Laura Benner, Colette Doerr-Harim, Solveig Tenckhoff, Johan F. Lock, Elmar-Marc Brede, Roberto Salvia, Enrico Polati, Jörg Köninger, Jan-Henrik Schiff, Uwe A. Wittel, Alexander Hötzel, Tobias Keck, Carla Nau, Anca-Laura Amati, Christian Koch, Thomas Eberl, Michael Zink, Ales Tomazic, Vesna Novak-Jankovic, Stefan Hofer, Markus K. Diener, Markus A. Weigand, Markus W. Büchler, Phillip Knebel; for the PAKMAN Trial Group |
E-Jahr: | 2020 |
Jahr: | May 27, 2020 |
Umfang: | 2 S. |
Fussnoten: | Gesehen am 30.10.2020 |
Titel Quelle: | Enthalten in: JAMA surgery |
Ort Quelle: | Chicago, Ill. : American Medical Association, 2013 |
Jahr Quelle: | 2020 |
Band/Heft Quelle: | 155(2020), 7, Seite e200794-e200794 |
ISSN Quelle: | 2168-6262 |
Abstract: | <h3>Importance</h3><p>Morbidity is still high in pancreatic surgery, driven mainly by gastrointestinal complications such as pancreatic fistula. Perioperative thoracic epidural analgesia (EDA) and patient-controlled intravenous analgesia (PCIA) are frequently used for pain control after pancreatic surgery. Evidence from a post hoc analysis suggests that PCIA is associated with fewer gastrointestinal complications.</p><h3>Objective</h3><p>To determine whether postoperative PCIA decreases the occurrence of gastrointestinal complications after pancreatic surgery compared with EDA.</p><h3>Design, Setting, and Participants</h3><p>In this adaptive, pragmatic, international, multicenter, superiority randomized clinical trial conducted from June 30, 2015, to October 1, 2017, 371 patients at 9 European pancreatic surgery centers who were scheduled for elective pancreatoduodenectomy were randomized to receive PCIA (n = 185) or EDA (n = 186); 248 patients (124 in each group) were analyzed. Data were analyzed from February 22 to April 25, 2019, using modified intention to treat and per protocol.</p><h3>Interventions</h3><p>Patients in the PCIA group received general anesthesia and postoperative PCIA with intravenous opioids with the help of a patient-controlled analgesia device. In the EDA group, patients received general anesthesia and intraoperative and postoperative EDA.</p><h3>Main Outcomes and Measures</h3><p>The primary end point was a composite of pancreatic fistula, bile leakage, delayed gastric emptying, gastrointestinal bleeding, or postoperative ileus within 30 days after surgery. Secondary end points included 30-day mortality, other complications, postoperative pain levels, intraoperative or postoperative use of vasopressor therapy, and fluid substitution.</p><h3>Results</h3><p>Among the 248 patients analyzed (147 men; mean [SD] age, 64.9 [10.7] years), the primary composite end point did not differ between the PCIA group (61 [49.2%]) and EDA group (57 [46.0%]) (odds ratio, 1.17; 95% CI, 0.71-1.95<i>P</i> = .54). Neither individual components of the primary end point nor 30-day mortality, postoperative pain levels, or intraoperative and postoperative substitution of fluids differed significantly between groups. Patients receiving EDA gained more weight by postoperative day 4 than patients receiving PCIA (mean [SD], 4.6 [3.8] vs 3.4 [3.6] kg;<i>P</i> = .03) and received more vasopressors (46 [37.1%] vs 31 [25.0%];<i>P</i> = .04). Failure of EDA occurred in 23 patients (18.5%).</p><h3>Conclusions and Relevance</h3><p>This study found that the choice between PCIA and EDA for pain control after pancreatic surgery should not be based on concerns regarding gastrointestinal complications because the 2 procedures are comparable with regard to effectiveness and safety. However, EDA was associated with several shortcomings.</p><h3>Trial Registration</h3><p>German Clinical Trials Register:DRKS00007784</p> |
DOI: | doi:10.1001/jamasurg.2020.0794 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext: https://doi.org/10.1001/jamasurg.2020.0794 |
| Volltext: https://jamanetwork.com/journals/jamasurgery/fullarticle/2765992 |
| DOI: https://doi.org/10.1001/jamasurg.2020.0794 |
Datenträger: | Online-Ressource |
Sprache: | eng |
K10plus-PPN: | 1737479826 |
Verknüpfungen: | → Zeitschrift |
Gastrointestinal complications after pancreatoduodenectomy with epidural vs patient-controlled intravenous analgesia / Klotz, Rosa [VerfasserIn]; May 27, 2020 (Online-Ressource)